Shire PLC (SHP) Earns “Buy” Rating from Kepler Capital Markets
Kepler Capital Markets reissued their buy rating on shares of Shire PLC (LON:SHP) in a report published on Friday. The firm currently has a GBX 4,600 ($60.50) price target on the biopharmaceutical company’s stock.
Other research analysts have also recently issued reports about the company. Jefferies Group LLC reiterated a buy rating on shares of Shire PLC in a research note on Tuesday, August 22nd. Citigroup Inc. reiterated a buy rating and issued a GBX 6,300 ($82.86) price target on shares of Shire PLC in a research note on Tuesday, August 22nd. Shore Capital reiterated a buy rating on shares of Shire PLC in a research note on Tuesday, August 15th. Deutsche Bank AG reiterated a buy rating and issued a GBX 6,000 ($78.92) price target on shares of Shire PLC in a research note on Friday, August 4th. Finally, Berenberg Bank reiterated a buy rating and issued a GBX 6,000 ($78.92) price target on shares of Shire PLC in a research note on Wednesday, August 9th. Three investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of Buy and an average target price of GBX 5,358.82 ($70.48).
Shire PLC (SHP) opened at GBX 3,626.50 ($47.70) on Friday. Shire PLC has a 12 month low of GBX 3,435.50 ($45.19) and a 12 month high of GBX 5,067 ($66.64).
TRADEMARK VIOLATION WARNING: “Shire PLC (SHP) Earns “Buy” Rating from Kepler Capital Markets” was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/11/20/shire-plc-shp-earns-buy-rating-from-kepler-capital-markets.html.
In other news, insider Flemming Ornskov bought 8,400 shares of Shire PLC stock in a transaction dated Tuesday, August 22nd. The stock was bought at an average cost of GBX 3,665 ($48.20) per share, for a total transaction of £307,860 ($404,919.11). Also, insider Anne Minto bought 190 shares of Shire PLC stock in a transaction dated Friday, September 29th. The stock was purchased at an average price of GBX 3,785 ($49.78) per share, with a total value of £7,191.50 ($9,458.77).
Shire PLC Company Profile
Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.